FDA Inspection 1270003 — Bio-Rad

Bio-Rad — FEI 3003992026

The FDA completed an inspection of Bio-Rad on May 16, 2025 in Steenvoorde. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
May 16, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Steenvoorde (France)

Citations

IDCFRDescription
343421 CFR 820.75(c)Documentation - review in response to changes or deviations

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.